Bringing the Benefits of eCOA BYOD Strategies to Clinical Studies
pharmaphorum
DECEMBER 13, 2022
They save on purchasing thousands of participant devices and the costs associated with connectivity, insurance, or replacement. Both the EMA and FDA have released draft guidance on the issue and are currently soliciting feedback. Security: Regulators may also harbor concerns about higher data privacy and security risks with BYOD.
59 
Let's personalize your content